The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
暂无分享,去创建一个
[1] W. C. Forrester,et al. High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Eick,et al. Expression of normal and translocated c‐myc alleles in Burkitt's lymphoma cells: evidence for different regulation. , 1989, The EMBO journal.
[3] M. Groudine,et al. Expression of replication-dependent histone genes in avian spermatids involves an alternate pathway of mRNA 3'-end formation , 1989, Molecular and cellular biology.
[4] J. Vieira,et al. 11 – Production of Single-Stranded Plasmid DNA , 1989 .
[5] J. Bishop,et al. DNA sequences that mediate attenuation of transcription from the mouse protooncogene myc. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Polack,et al. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation. , 1988, Oncogene.
[7] R. Lucito,et al. Elements required for transcription initiation of the human U2 snRNA gene coincide with elements required for snRNA 3′ end formation. , 1988, The EMBO journal.
[8] C. June,et al. Multiple mechanisms regulate c‐myc gene expression during normal T cell activation. , 1988, The EMBO journal.
[9] L. Lau,et al. c-myc can induce expression of G0/G1 transition genes. , 1988, Molecular and cellular biology.
[10] K. Nishikura,et al. The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells. , 1988, Oncogene.
[11] M. Groudine,et al. Sequence requirements for premature termination of transcription in the human c-myc gene , 1988, Cell.
[12] S. Freytag. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1 , 1988, Molecular and cellular biology.
[13] R. Eisenman,et al. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas , 1988, Cell.
[14] M. Groudine,et al. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. , 1987, Science.
[15] Joyce Li,et al. An elongation control particle containing the N gene transcriptional antitermination protein of bacteriophage lambda , 1987, Cell.
[16] K. Yokoyama,et al. Transcriptional control of the endogenous MYC protooncogene by antisense RNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Lachman,et al. Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells. , 1987, Genes & development.
[18] S. Barik,et al. An antitermination protein engages the elongating transcription apparatus at a promoter-proximal recognition site , 1987, Cell.
[19] J. Vieira,et al. Production of single-stranded plasmid DNA. , 1987, Methods in enzymology.
[20] A. Polack,et al. Transcription of c-myc in human mononuclear cells is regulated by an elongation block. , 1987, Oncogene.
[21] B. Lebleu,et al. Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. , 1986, Nucleic acids research.
[22] D. Eick,et al. Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. , 1986, Nucleic acids research.
[23] K. Marcu,et al. Intragenic pausing and anti‐sense transcription within the murine c‐myc locus. , 1986, The EMBO journal.
[24] H. E. N. D. Vegvar,et al. 3′ end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters , 1986, Cell.
[25] E. Dmitrovsky,et al. Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line , 1986, Nature.
[26] Mark Groudine,et al. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.
[27] P. Pelicci,et al. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Lacy,et al. Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Hayday,et al. Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells , 1986, Molecular and cellular biology.
[30] M. Cole. The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.
[31] C. Denny,et al. Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement , 1985, Molecular and cellular biology.
[32] C. Dani,et al. c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors , 1985, Nature.
[33] J. Blanchard,et al. Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors , 1985, Cell.
[34] Jeffrey W. Roberts,et al. Phage lambda gene Q antiterminator recognizes RNA polymerase near the promoter and accelerates it through a pause site , 1985, Cell.
[35] S. Bauer,et al. Chromosome translocations clustered 5′ of the murine c‐myc gene qualitatively affect promoter usage: implications for the site of normal c‐myc regulation. , 1985, The EMBO journal.
[36] K. Nishikura,et al. Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes , 1985, Molecular and cellular biology.
[37] W. S. Hayward,et al. Activation of a translocated c-myc gene: role of structural alterations in the upstream region. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[38] P. Leder,et al. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[39] T. Rabbitts,et al. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma , 1984, Nature.
[40] P. Leder,et al. Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in burkitt lymphoma , 1984, Cell.
[41] S. Latt,et al. A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphoma , 1984, Cell.
[42] C. Croce,et al. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[43] C. Croce,et al. Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids. , 1984, Science.
[44] P. Leder,et al. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells , 1984, Cell.
[45] F. Galibert,et al. Nucleotide sequence of the human c‐myc locus: provocative open reading frame within the first exon. , 1984, The EMBO journal.
[46] J Erikson,et al. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. , 1983, Science.
[47] B. Howard,et al. High efficiency DNA-mediated transformation of primate cells. , 1983, Science.